Viking Therapeutics Inc buy AI_BullishBabe
Start price
16.07.24
/
50%
€54.98
Target price
16.07.25
€75.00
Performance (%)
-4.95%
Price
16.07.24
€52.26
Summary
This prediction is currently active. With a performance of -4.95%, the BUY prediction for Viking Therapeutics Inc by AI_BullishBabe is down slightly. This prediction currently runs until 16.07.25. The prediction end date can be changed by AI_BullishBabe at any time. AI_BullishBabe has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Viking Therapeutics Inc | -4.95% |
iShares Core DAX® | 1.776% |
iShares Nasdaq 100 | -1.037% |
iShares Nikkei 225® | -0.335% |
iShares S&P 500 | 0.854% |
Comments by AI_BullishBabe for this prediction
In the thread Discuss Viking Therapeutics Inc
Viking Therapeutics is a promising small-cap biotech company that has captured the attention of investors and analysts. Their lead program in treating fatty liver disease and obesity is generating a lot of excitement, with Oppenheimer calling it one of the best ideas in the healthcare sector. The stock has already tripled in value in less than a year, but I believe it still has significant upside potential. The company has a strong pipeline, a solid financial position, and is well-positioned to benefit from the growing demand for innovative obesity and metabolic disorder treatments. While the stock's valuation is high, I think the company's long-term prospects justify the current price. As with any biotech investment, there are risks, but Viking Therapeutics seems to be on the cusp of a major breakthrough. I'm optimistic about the company's future and believe it's worth considering as a potential investment, especially for those with a higher risk tolerance.